Related Experiment Video

Updated: Jun 19, 2026

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
06:27

Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells

Published on: May 6, 2013

CD40 expression and its association with low-grade inflammation in a Greek population of type 1 diabetic juveniles:

A E Chatzigeorgiou1, P E Lembessis, C F Mylona-Karagianni

  • 1Department of Experimental Physiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.

Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association
|October 17, 2009
PubMed

Insights

CD40 signalling is implicated in type 1 diabetes (T1DM) pathogenesis. Elevated CD40 markers in T1DM patients, particularly those with poor glycemic control, correlate with increased inflammation, suggesting a key role in disease progression.

Area of Science:

  • Immunology
  • Endocrinology
  • Molecular Biology

Background:

  • CD40 signalling is linked to autoimmune diseases and chronic inflammation.
  • Understanding CD40's role in early-stage type 1 diabetes (T1DM) is crucial.

Purpose of the Study:

  • To examine CD40 system component expression in T1DM patients.
  • To correlate plasma and urine CD40 levels with inflammatory markers in T1DM.

Main Methods:

  • Analyzed plasma, urine, and PBMCs from 70 T1DM patients and 40 healthy controls.
  • Utilized ELISA, western-blot, RT-PCR, and DNA sequencing.

Main Results:

  • T1DM patients showed higher plasma soluble CD40 (sCD40) linked to elevated IL-6, MMP-9, and CRP.
  • Elevated urinary sCD40 suggested increased CD40 production, not reduced excretion.
  • PBMCs in T1DM patients exhibited CD40 upregulation, correlating with inflammatory markers.

Conclusions:

  • CD40 dysregulation is associated with inflammation in T1DM.
  • Poor glycemic control in T1DM exacerbates CD40 upregulation and inflammation.
  • CD40 plays a pathophysiological role in the low-grade inflammation of T1DM.
Abstract

More Related Videos

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions09:41

Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions

Published on: October 17, 2017

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...